跳转至内容
Merck

06855

Sigma-Aldrich

Kollisolv ® PEG E 400

别名:

聚(乙二醇), Lutrol E 400, Macrogol 400, 聚乙二醇400, PEG

登录查看公司和协议定价


About This Item

线性分子式:
H(OCH2CH2)nOH
CAS号:
MDL號碼:
分類程式碼代碼:
12161900
NACRES:
NA.25

形狀

liquid

分子量

average Mw 380-420 g/mol (from OH-value (56100*2/OHZ))

技術

electrophoresis: suitable

雜質

reducing substances, complies
≤0.1% sulfated ash
≤0.25% ethylene glycol and diethylene glycol (sum)
≤0.5 g acetic acid (per 100 g)
≤1 ppm ethylene oxide
≤1 ppm lead (verified on random samples only)
≤1.0% water
≤10 ppm dioxan
≤15 ppm formaldehyde
≤5 ppm heavy metals (verfied on random samples only)
≤620 ppm ethylene glycol

pH值

4.5-7.0 (50 g/L)

黏度

105-130 mPa.s(20 °C) (6.8-8.0 CS (98.9°C)

羥值

267‑295 mg KOH/g

溶解度

H2O: 10%, clear, colorless

適合性

complies for acidity or alkalinity

SMILES 字串

C(CO)O

InChI

1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2

InChI 密鑰

LYCAIKOWRPUZTN-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

應用

Kollisolv聚乙二醇 在制药工业中被用作增稠剂和凝胶粘合剂。
该研究级产品仅供研发使用。

其他說明

Kollisolv的 PEG E 级为不同分子量的聚乙二醇(聚乙二醇)。

法律資訊

Kollisolv is a registered trademark of BASF

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

I L Konorova et al.
Patologicheskaia fiziologiia i eksperimental'naia terapiia, (4)(4), 7-9 (1991-07-01)
The search for antiaggregatory compounds is undertaken, as a rule, under in vitro conditions which do not reflect the dynamics of the real process. The present work deals with study of the peculiarities of the development of the collagen induced
P I Polimeni et al.
Journal of cardiovascular pharmacology, 14(3), 374-380 (1989-09-01)
The acute hemodynamic effects of an intravenously (i.v.) injected poly(ethylene oxide), Polyox WSR N-60K (dose 50 mg/kg), were studied in the open-chest rat anesthetized with sodium pentobarbital. The injectate is one of four drag-reducing polymers known to augment in vitro
M Patel Geeta et al.
Current drug delivery, 6(2), 159-165 (2009-05-20)
Carbamazepine indicated for the control of epilepsy, undergoes extensive hepatic first-pass metabolism after oral administration. A vaginal dosage form of carbamazepine is not commercially available. Conventional suppository having poor retention in the vaginal tract, as they are removed in a
D D Smyth et al.
Cardiovascular drugs and therapy, 4(1), 297-300 (1990-02-01)
Previous studies have demonstrated that Separan AP-30, a drag-reducing polymer, significantly decreased the formation of atherosclerotic plaques in rabbits fed a high-cholesterol diet. Furthermore, Separan AP-273, a polymer similar to but longer than Separan AP-30, markedly increased cardiac output in

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门